Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Torben Riis, Rasmussen"'
Autor:
Torben Riis Rasmussen, Anja Gouliaev, Erik Jakobsen, Karin Hjorthaug, Lene Unmack Larsen, Peter Meldgaard, Jesper Thygesen, Rana Bibi, Lars B. Møller, Arman Arshad, Birgitte Folkersen, Anette Højsgaard, Zaigham Saghir, Klaus R. Larsen, Jesper Ravn
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Introduction This study aimed to evaluate the consistency of lung cancer case assessments across multidisciplinary team (MDT) sites in Denmark. The goal was to appraise the comparability of outcomes between hospitals in a real-world context.
Externí odkaz:
https://doaj.org/article/f0da2178d14641f49b9f1ff78418e02d
Autor:
Marianne Steding-Jessen, Henriette Engberg, Erik Jakobsen, Torben Riis Rasmussen, Henrik Møller
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: There has been marked progress against lung cancer in Denmark. To gain further insight into the different aspects of the improvement, we examined the stage-specific incidence rates, stage-specific survival and mortality rates.
Externí odkaz:
https://doaj.org/article/10d8c053d9c943e4b097db55df97dbd7
Publikováno v:
Diagnostics, Vol 14, Iss 2, p 233 (2024)
[¹⁸F]Fluorodeoxyglucose positron emission tomography/computed tomography ([¹⁸F]FDG PET/CT) is a valuable imaging tool in the post-treatment management of non-small-cell lung cancer (NSCLC). This study aimed to investigate the trends in utilizat
Externí odkaz:
https://doaj.org/article/b9f9a9db136f4301ba9bae3523480810
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 2, Pp 630-635 (2022)
Spontaneous regression of cancer is an extremely rare phenomenon, and it has been described in only a few cases of pulmonary cancer. We report a case of complete spontaneous regression of squamous-cell lung cancer (SCLC) following a core needle biops
Externí odkaz:
https://doaj.org/article/11ab2de5e6aa40c18a8760733c8deb85
Autor:
Charlotte Hyldgaard, Christian Trolle, Stefan Markus Walbom Harders, Henriette Engberg, Torben Riis Rasmussen, Henrik Møller
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background At Silkeborg Regional Hospital, Denmark, the number of stage IA lung cancer increased after implementation of increased use of CT investigations and a corresponding reduction in chest X-ray. The aim of the present study was to und
Externí odkaz:
https://doaj.org/article/28bbf97dc728496999baec7f4caa54ee
Autor:
Anja Gouliaev, Jeyanthini Risikesan, Niels Lyhne Christensen, Torben Riis Rasmussen, Ole Hilberg, Rikke Ibsen, Anders Løkke
Publikováno v:
European Clinical Respiratory Journal, Vol 8, Iss 1 (2021)
Background: Lung cancer is the leading cause of cancer death worldwide, but the additional economic burden regarding direct and indirect costs is largely unknown. This study provides information on the economic consequences of lung cancer on a nation
Externí odkaz:
https://doaj.org/article/ea73b92ef90c447daa8424617fed3e83
Autor:
Rikke Hjortebjerg, Ulrick Espelund, Torben Riis Rasmussen, Birgitte Folkersen, Torben Steiniche, Jeanette Bæhr Georgsen, Claus Oxvig, Jan Frystyk
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
Pregnancy-associated plasma protein-A (PAPP-A) and its homolog PAPP-A2 are enzymes that modulate the availability and mitogenic activity of insulin-like growth factor-I (IGF-I). PAPP-A has been implicated in numerous cancers but reports on PAPP-A2 in
Externí odkaz:
https://doaj.org/article/755f8bd31db64be9a576d86acd63897e
Autor:
Tina Bech Olesen, Torben Riis Rasmussen, Erik Jakobsen, Henriette Engberg, Ole Hilberg, Henrik Møller, Jens Winther Jensen, Henry Jensen
Publikováno v:
Olesen, T B, Rasmussen, T R, Jakobsen, E, Engberg, H, Hilberg, O, Møller, H, Jensen, J W & Jensen, H 2023, ' Diagnosis and treatment of lung cancer in Denmark during the COVID-19 pandemic ', Cancer epidemiology, vol. 85, 102373 . https://doi.org/10.1016/j.canep.2023.102373
Background: We examined the number of lung cancers diagnosed, the quality of care and the socio-economic and clinical characteristics among patients with lung cancer during the COVID-19 pandemic compared to previous years. Methods: We included all pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55f0e995192a4121d8b3e72e3751519d
https://pure.au.dk/portal/da/publications/diagnosis-and-treatment-of-lung-cancer-in-denmark-during-the-covid19-pandemic(3c6d79e6-b04a-4010-8308-e09cf32b583a).html
https://pure.au.dk/portal/da/publications/diagnosis-and-treatment-of-lung-cancer-in-denmark-during-the-covid19-pandemic(3c6d79e6-b04a-4010-8308-e09cf32b583a).html
Autor:
Birgitte Sandfeld-Paulsen, Birgitte Holst Folkersen, Torben Riis Rasmussen, Peter Meldgaard, Boe S. Sorensen
Publikováno v:
Translational Oncology, Vol 9, Iss 4, Pp 306-312 (2016)
OBJECTIVES: Contradicting results have been demonstrated for the expression of the epidermal growth factor receptor (EGFR) as a prognostic marker in non–small cell lung cancer (NSCLC). The complexity of the EGF system with four interacting receptor
Externí odkaz:
https://doaj.org/article/bad7257882204646b7b6aa2e006ecd2b
Autor:
Elizabeth Hedgeman, Jon P. Fryzek, Lars Pedersen, Deirdre Cronin-Fenton, Mette Nørgaard, Torben Riis Rasmussen, Naimisha Movva, Tapashi Dalvi, Stephen Hamilton-Dutoit, Hanh Hansen, Anders Mellemgaard, Norah J. Shire
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Cronin-Fenton, D, Dalvi, T, Movva, N, Pedersen, L, Hansen, H, Fryzek, J, Hedgeman, E, Mellemgaard, A, Rasmussen, T R, Shire, N, Hamilton-Dutoit, S & Nørgaard, M 2021, ' PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients : a Danish cohort study ', Scientific Reports, vol. 11, no. 1, 16892 . https://doi.org/10.1038/s41598-021-96486-2
Cronin-Fenton, D, Dalvi, T, Movva, N, Pedersen, L, Hansen, H, Fryzek, J, Hedgeman, E, Mellemgaard, A, Rasmussen, T R, Shire, N, Hamilton-Dutoit, S & Nørgaard, M 2021, ' PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients : a Danish cohort study ', Scientific Reports, vol. 11, no. 1, pp. 16892 . https://doi.org/10.1038/s41598-021-96486-2
Scientific Reports
Cronin-Fenton, D, Dalvi, T, Movva, N, Pedersen, L, Hansen, H, Fryzek, J, Hedgeman, E, Mellemgaard, A, Rasmussen, T R, Shire, N, Hamilton-Dutoit, S & Nørgaard, M 2021, ' PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients : a Danish cohort study ', Scientific Reports, vol. 11, no. 1, 16892 . https://doi.org/10.1038/s41598-021-96486-2
Cronin-Fenton, D, Dalvi, T, Movva, N, Pedersen, L, Hansen, H, Fryzek, J, Hedgeman, E, Mellemgaard, A, Rasmussen, T R, Shire, N, Hamilton-Dutoit, S & Nørgaard, M 2021, ' PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients : a Danish cohort study ', Scientific Reports, vol. 11, no. 1, pp. 16892 . https://doi.org/10.1038/s41598-021-96486-2
Scientific Reports
Programmed cell death receptor ligand-1 (PD-L1) expression, KRAS (KRASm) and EGFR (EGFRm) mutations may influence non-small cell lung cancer (NSCLC) prognosis. We aimed to evaluate PD-L1 expression, KRASm, and EGFRm and survival among stage III unres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c714e5100877d9c2cba31cc1cb53eae7
https://doaj.org/article/b4c1a9ab9ce54222a8cc1b0d41e549b9
https://doaj.org/article/b4c1a9ab9ce54222a8cc1b0d41e549b9